According to Standard BioTools's latest financial reports the company has a price-to-book ratio of 3.11605.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.38 | -220.5% |
2023-12-31 | -1.15 | 0.89% |
2022-12-31 | -1.14 | -135.73% |
2021-12-31 | 3.19 | -0.9% |
2020-12-31 | 3.22 | 102.96% |
2019-12-31 | 1.58 | -73.13% |
2018-12-31 | 5.90 | -19.86% |
2017-12-31 | 7.36 | 84.79% |
2016-12-31 | 3.98 | 46.74% |
2015-12-31 | 2.71 | -57.3% |
2014-12-31 | 6.36 | -37.99% |
2013-12-31 | 10.2 | 187.03% |
2012-12-31 | 3.57 | -23.74% |
2011-12-31 | 4.68 | |
2010-12-31 | N/A | |
2009-12-31 | N/A | |
2008-12-31 | N/A | |
2007-12-31 | N/A |